Patents by Inventor Siok Ping Yeo

Siok Ping Yeo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL2Rbeta/common gamma chain antibodies
    Patent number: 10472423
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: November 12, 2019
    Assignee: Agency For Science, Technology and Research
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly
  • Anti-TIM-3 antibodies
    Patent number: 10435466
    Abstract: Anti-TIM-3 antibodies are disclosed, as well as pharmaceutical compositions comprising such antibodies, and uses and methods using the same, such as in the treatment of cancer or infectious disease or T-cell dysfunctional disorders. Bispecific antibodies against TIM-3 and other targets are also disclosed, with a preferred embodiment of a bispecific antibody against TIM-3 and CD3.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: October 8, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh
  • Anti-PD-1 Antibodies
    Publication number: 20190292261
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: March 21, 2019
    Publication date: September 26, 2019
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • Anti-TIM-3 Antibodies
    Publication number: 20190185564
    Abstract: Anti-TIM-3 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: March 6, 2019
    Publication date: June 20, 2019
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh
  • Anti-CTLA-4 Antibodies
    Publication number: 20190153097
    Abstract: Anti-CTLA-4 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 23, 2019
    Inventors: Cheng-I WANG, Eve NGOH, Siok Ping YEO
  • IL-1BETA NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
    Publication number: 20190144535
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: November 15, 2018
    Publication date: May 16, 2019
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-l Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Anti-PD-1 antibodies
    Patent number: 10280224
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: May 7, 2019
    Assignee: Agency For Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • Anti-TIM-3 antibodies
    Patent number: 10259874
    Abstract: Anti-TIM-3 antibodies are disclosed, as well as pharmaceutical compositions comprising such antibodies, and uses and methods using the same, such as in the treatment of cancer, infectious diseases, or T-cell dysfunctional disorders. Bispecific antibodies against TIM-3 and other targets are also disclosed, with preferred embodiment of a bispecific antibody against TIM-3 and CD3.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: April 16, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh
  • IL-2R beta/common gamma chain antibodies
    Patent number: 10246512
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: April 2, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly
  • ANTI-LAG-3 ANTIBODIES
    Publication number: 20190040136
    Abstract: Anti-LAG-3 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: March 3, 2017
    Publication date: February 7, 2019
    Inventors: Cheng-I WANG, Hsueh Ling Janice OH, Siok Ping YEO, Chia Yin LEE
  • IL-1? neutralizing human monoclonal antibodies
    Patent number: 10167335
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: January 1, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Method of treating cancer using IL2R beta/common gamma chain antibodies
    Patent number: 10167338
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: January 1, 2019
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20180362655
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 20, 2018
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20180237528
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 23, 2018
    Inventors: Cheng-I WANG, Peter BRAUER, Siok Ping YEO, Hwee Ching TAN, John Edward CONNOLLY
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20180208663
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 26, 2018
    Inventors: Cheng-I WANG, Peter BRAUER, Siok Ping YEO, Hwee Ching TAN, John Edward CONNOLLY
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20180194853
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 12, 2018
    Inventors: Cheng-I WANG, Peter BRAUER, Siok Ping YEO, Hwee Ching TAN, John Edward CONNOLLY
  • Anti-PD-L1 Antibodies
    Publication number: 20180002423
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and methods of using such antibodies to restore T-cell function in T-cells exhibiting T-cell exhaustion or T-cell anergy.
    Type: Application
    Filed: January 4, 2016
    Publication date: January 4, 2018
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • Anti-PD-L1 Antibodies
    Publication number: 20170319690
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: June 15, 2017
    Publication date: November 9, 2017
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • Anti-PD-1 Antibodies
    Publication number: 20170313774
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: October 27, 2015
    Publication date: November 2, 2017
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • Anti-TIM-3 Antibodies
    Publication number: 20170306016
    Abstract: Anti-TIM-3 antibodies are disclosed, as well as pharmaceutical compositions comprising such antibodies, and uses and methods using the same, such as in the treatment of cancer or infectious disease or T-cell dysfunctional disorders. Bispecific antibodies against TIM-3 and other targets are also disclosed, with a preferred embodiment of a bispecific antibody against TIM-3 and CD3.
    Type: Application
    Filed: October 27, 2015
    Publication date: October 26, 2017
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh